title: Serum chromogranin A reflects regression of metastatic carcinoid during prolonged octreotide treatment.
authors.affiliation: 2nd Department of Medicine, Semmelweis University, 46 Szentkiralyi, Budapest 1088, Hungary. pregunistvan@yahoo.com
authors.forename: Istvan
authors.initials: I
authors.lastname: Pregun
authors.forename: Peter
authors.initials: P
authors.lastname: Gergics
authors.forename: Gabriella
authors.initials: G
authors.lastname: Dabasi
authors.forename: Peter
authors.initials: P
authors.lastname: Igaz
authors.forename: Karoly
authors.initials: K
authors.lastname: Racz
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Tulassay
mesh_terms: D001327:Autoimmune Diseases / Q000150:complications; D002276:Carcinoid Tumor / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D053379:Chromogranin A / Q000097:blood*; D005260:Female; D005756:Gastritis / Q000150:complications / Q000276:immunology; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000556:secondary; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D014057:Tomography, X-Ray Computed
chemical_list: D053379:Chromogranin A; D015282:Octreotide